Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool aims to improve diabetes diagnosis in primary care

NCT ID NCT06711718

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a computer tool that helps doctors classify the type of diabetes in adults diagnosed before age 50. Researchers interviewed 21 patients and staff to see if the tool was useful and acceptable. The goal is to gather initial data for a future, larger trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a decision-support tool that helps doctors identify the right diabetes type earlier, improving treatment choices.
What could go wrong
This is a very small, completed study with only 21 participants, so results may not apply widely. It only tested the tool's use and acceptance, not its impact on health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

21 people

The number who actually took part.

Started

Jun 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who have had a review of their diabetes diagnosis as a result of the running of the tool will be invited to interview. Clinical practice staff (GP and/or nurse) who have been involved in reviewing patients flagged following running of the tool will be invited to interview. Practice Manager or administrator who has run the searches and tool will be invited to interview.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Eligibility criteria for qualitative interviews. Inclusion Criteria: Patients * Able to give written informed consent * 18 years of age or over at the time of study participation * Diabetes diagnosed at or under the age of 50 * Registered with a participating GP practice * Sufficient understanding of the English Language to enable completion of the interview Staff * Able to give written informed consent * 18 years of age or over * Working at a participating General Practice and directly involved with the study procedures (eg running the decision support tool, responsibility for clinical care of diabetes patients) Exclusion Criteria: Patients * Unable to give written informed consent * Under 18 years of age * No diabetes or diabetes diagnosed over the age of 50. * Not registered with a participating GP practice * Insufficient understanding of the English Language to enable interview completion * Have an opt-out code where patient has declined electronic medical records examined * Considered by their General Practitioner(s) to be inappropriate to recruit due to psycho-social reasons, participating in another related clinical trial or significant health reasons, e.g. terminal illness/diagnosis. Staff * Unable to give written informed consent * Under 18 years of age * General Practice staff not involved with the study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chaddlewood Surgery (Beacon Medical Group)

    Plymouth, Devon, PL7 2QP, United Kingdom

  • Chilwell Valley and Meadows Practice

    Nottingham, Nottinghamshire, NG9 6DX, United Kingdom

  • Hucknall Road Medical Centre

    Nottingham, Nottinghamshire, NG5 1NA, United Kingdom

  • Ivybridge Medical Practice (Beacon Medical Group)

    Ivybridge, Devon, PL21 0AJ, United Kingdom

  • Parkside Medical Practice

    Nottingham, Nottinghamshire, NG6 8QJ, United Kingdom

  • Pathfields Medical Group

    Plymouth, Devon, PL7 1AD, United Kingdom

  • Plympton Health Centre (Beacon Medical Group)

    Plymouth, Devon, PL7 1AD, United Kingdom

  • Roborough Surgery

    Plymouth, Devon, PL6 6PH, United Kingdom

  • Tamar Valley Health

    Plymouth, Cornwall, PL17 7AW, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.